On the morning of October 19, 2017, a delegation consisting of Shao Yuanchang, Deputy Director of the Provincial Food and Drug Administration, Chen Yuehua, Director of the Safety Supervision Division, and Wang Weidong, Director of the Certification and Inspection Center, accompanied by Xia Haiguo, Director of the Market Supervision Bureau, visited Zhejiang Benefit Pharmaceutical for research and guidance, and a symposium was held.

Accompanied by the senior management of the company, Deputy Director Shao and his entourage inspected various production workshops and laboratories of the enterprise, gaining an in-depth understanding of the production, research and development, and quality control measures of the enterprise's traditional Chinese medicine formula granules.

At the symposium, Chairman Wu Lihua made a detailed report to Deputy Director Shao and his delegation on the company's development and production status, with a focus on introducing the production progress of "traditional Chinese medicine formula granules" and the layout plan for the company's future development.

After listening to the report, Director Xia stated that as the first pilot manufacturer of "traditional Chinese medicine formula granules" in Lishui, Zhejiang Benefit Pharmaceutical should solidly engage in its core business, prioritize ensuring product quality, improving production processes, and optimizing the production environment, earnestly carry out the production and promotion of "traditional Chinese medicine formula granules", effectively promote the development of the traditional Chinese medicine industry in Lishui, drive the Chinese medicinal materials planting industry, and increase farmers' income. Deputy Director Shao, after the on-site research, put forward requirements for the future development of Benefit Pharmaceutical. Benefit Pharmaceutical should lay a solid foundation, leverage the unique advantages of Lishui, promote the development of Lishui's green ecological industry. Product quality is the foundation of an enterprise's development, so it is necessary to strengthen the awareness of product quality control, improve product quality, and make joint efforts to promote the healthy and standardized development of traditional Chinese medicine formula granules in Zhejiang Province.

Finally, the chairman stated that Benefit Pharmaceutical will consistently adhere to its original aspiration and go all out to advance the traditional Chinese medicine formula granules project. Traditional Chinese medicine formula granules, though a kind of product, are in essence more of a culture.